Patents by Inventor James Jeffries

James Jeffries has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11951792
    Abstract: A detected displacement of a marker on a vehicle is determined based on image data captured while the vehicle traverses a displacement object of a ground surface. Then a health status of a suspension component of the vehicle is determined to be unhealthy based on comparing the detected displacement of the marker to a target displacement of the marker. The target displacement specifies displacement of the marker that indicates the suspension component is healthy. The vehicle is operated based on the suspension component being unhealthy.
    Type: Grant
    Filed: February 24, 2020
    Date of Patent: April 9, 2024
    Assignee: Ford Global Technologies, LLC
    Inventors: Devon Eyerman, Jonathan Barker, Dexin Wang, Austin James Jeffries
  • Publication number: 20210260950
    Abstract: A detected displacement of a marker on a vehicle is determined based on image data captured while the vehicle traverses a displacement object of a ground surface. Then a health status of a suspension component of the vehicle is determined to be unhealthy based on comparing the detected displacement of the marker to a target displacement of the marker. The target displacement specifies displacement of the marker that indicates the suspension component is healthy. The vehicle is operated based on the suspension component being unhealthy.
    Type: Application
    Filed: February 24, 2020
    Publication date: August 26, 2021
    Applicant: Ford Global Technologies, LLC
    Inventors: Devon Eyerman, Jonathan Barker, Dexin Wang, Austin James Jeffries
  • Patent number: 9773225
    Abstract: An apparatus, system, and method are disclosed for social network job applications. A method for submitting a job includes receiving details for a job posting from a job poster and the job posting corresponds to an employment position. The method includes providing the job posting for viewing on a job board by one or more users of a social network. Each account includes a user profile storing user information. The method includes receiving a request from a user to apply for the employment position corresponding to the job board posting. The method also includes submitting a job application for viewing by the job poster. The job application includes at least a portion of the user information from the user profile corresponding to the user. At least a portion of the user information included in the job application is pulled from the user profile.
    Type: Grant
    Filed: September 28, 2011
    Date of Patent: September 26, 2017
    Inventor: James Jeffries
  • Patent number: 9718796
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, fibrotic disease, cardiovascular disease, infectious disease, inflammatory disorder, graft rejection, or graft-versus-host disease.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: August 1, 2017
    Assignees: VENTIRX PHARMACEUTICALS, INC., ARRAY BIOPHARMA, INC.
    Inventors: James Jeffry Howbert, Robert Hershberg, Laurence E. Burgess, Hong Woon Yang
  • Patent number: 9655904
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-versus-host disease.
    Type: Grant
    Filed: August 4, 2015
    Date of Patent: May 23, 2017
    Assignees: VENTIRX PHARMACEUTICALS, INC., ARRAY BIOPHARMA, INC.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos, Brad Newhouse, Hong-Woon Yang
  • Patent number: 9456921
    Abstract: Bi- or multiphasic, clear or translucent silicone-containing lubricant compositions, and products including such compositions and methods of making such compositions and products are disclosed. The refractive index of each immiscible phase of the lubricant composition is matched to that of each other phase to make the composition clear or translucent. The compositions are highly lubricious, non-staining, and easily washable.
    Type: Grant
    Filed: May 29, 2012
    Date of Patent: October 4, 2016
    Assignee: CHEMSIL SILICONES, INC.
    Inventors: James Jeffries Harrison, Guillermo Hernandez
  • Publication number: 20160137608
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Application
    Filed: October 13, 2015
    Publication date: May 19, 2016
    Applicants: VENTIRX PHARMACEUTICALS, INC., ARRAY BIOPHARMA, INC.
    Inventors: James Jeffry Howbert, Gregory N. Dietsch, Robert Hershberg, Laurence E. Burgess, George A. Doherty, C. Todd Eary, Robert D. Groneberg, Zachery Jones
  • Publication number: 20160129010
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-versus-host disease.
    Type: Application
    Filed: August 4, 2015
    Publication date: May 12, 2016
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos, Brad Newhouse, Hong-Woon Yang
  • Patent number: 9242964
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Grant
    Filed: September 3, 2013
    Date of Patent: January 26, 2016
    Assignees: VENTIRX PHARMACEUTICALS, INC., ARRAY BIOPHARMA, INC.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert M. Hershberg, Laurence E. Burgess, George A. Doherty, C. Todd Eary, Robert D. Groneberg, Zachary Jones
  • Patent number: 9126940
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Grant
    Filed: February 14, 2014
    Date of Patent: September 8, 2015
    Assignees: VentiRx Pharmaceuticals, Inc., Array Biopharma, Inc.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos, Brad Newhouse, Hong-Woon Yang
  • Publication number: 20150119369
    Abstract: The present invention relates to compositions including anhydrous compositions which include a dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products.
    Type: Application
    Filed: October 29, 2014
    Publication date: April 30, 2015
    Inventors: James Jeffries Harrison, Nohemi Harrison
  • Patent number: 8900607
    Abstract: The present invention relates to compositions including anhydrous compositions which include dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products which may include retinoic acid, retinoic acid derivatives, retinal, retinol and/or retinyl esters.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: December 2, 2014
    Assignee: Chemsil Silicones, Inc.
    Inventors: James Jeffries Harrison, Nohemi Harrison
  • Patent number: 8852615
    Abstract: The present invention relates to compositions including anhydrous compositions which include a dimethicone crosspolymer and/or dimethicone elastomer gum and one or more skin care products which may include retinoic acid, retinoic acid derivatives, retinal, retinol and/or retinyl esters, and methods of making, storing, and using such compositions.
    Type: Grant
    Filed: February 18, 2011
    Date of Patent: October 7, 2014
    Assignee: Chemsil Silicones, Inc.
    Inventors: James Jeffries Harrison, Nohemi Harrison
  • Publication number: 20140234376
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Application
    Filed: February 14, 2014
    Publication date: August 21, 2014
    Applicants: Array BioPharma, Inc., VentiRx Pharmaceuticals, Inc.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos, Brad Newhouse, Hong-Woon Yang
  • Publication number: 20140142086
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Application
    Filed: September 3, 2013
    Publication date: May 22, 2014
    Applicants: ARRAY BIOPHARMA, INC., VENTIRX PHARMACEUTICALS, INC.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert M. Hershberg, Laurence E. Burgess, George A. Doherty, C. Todd Eary, Robert D. Groneberg, Zachary Jones
  • Patent number: 8691809
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: April 8, 2014
    Assignees: VentiRx Pharmaceuticals, Inc., Array BioPharma, Inc.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, Joseph P. Lyssikatos, Brad Newhouse, Hong Woon Yang
  • Publication number: 20140088085
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, fibrotic disease, cardiovascular disease, infectious disease, inflammatory disorder, graft rejection, or graft-versus-host disease.
    Type: Application
    Filed: January 12, 2012
    Publication date: March 27, 2014
    Applicants: ARRAY BIOPHARMA, INC, VENTIRX PHARMACEUTICALS, INC
    Inventors: Laurence E. Burgess, George A. Doherty, C. Todd Eary, Robert D. Groneberg, Zachary Jones, James Jeffry Howbert, Robert Hershberg, Joseph P. Lyssikatos, Hong Woon Yang
  • Publication number: 20140066432
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, fibrotic disease, cardiovascular disease, infectious disease, inflammatory disorder, graft rejection, or graft-versus-host disease.
    Type: Application
    Filed: January 12, 2012
    Publication date: March 6, 2014
    Inventors: James Jeffry Howbert, Robert Hershberg, Laurence E. Burgess, Hong Woon Yang
  • Patent number: 8524702
    Abstract: Provided are compositions and methods useful for modulation of signaling through the Toll-like receptors TLR7 and/or TLR8. The compositions and methods have use in treating or preventing disease, including cancer, autoimmune disease, infectious disease, inflammatory disorder, graft rejection, and graft-verses-host disease.
    Type: Grant
    Filed: August 18, 2010
    Date of Patent: September 3, 2013
    Assignees: VentiRx Pharmaceuticals, Inc., Array BioPharma, Inc.
    Inventors: James Jeffry Howbert, Gregory Dietsch, Robert Hershberg, Laurence E. Burgess, George A. Doherty, C. Todd Eary, Robert D. Groneberg, Zachary Jones
  • Publication number: 20120294820
    Abstract: Bi- or multiphasic, clear or translucent silicone-containing lubricant compositions, and products including such compositions and methods of making such compositions and products are disclosed. The refractive index of each immiscible phase of the lubricant composition is matched to that of each other phase to make the composition clear or translucent. The compositions are highly lubricious, non-staining, and easily washable.
    Type: Application
    Filed: May 29, 2012
    Publication date: November 22, 2012
    Applicant: CHEMSIL SILICONES, INC.
    Inventors: James Jeffries Harrison, Guillermo Hernandez